A prospective clinical study of 20 initially asymptomatic HTLV-Iseropositive carriers was
commenced in 1991 to determine the natural history of the infection in relation to HTLV-I …

Human T-cell lymphotropic virus type I (HTLV-I) is known to cause adult T-cell leukemia/T-
cell lymphoma and tropical spastic paraparesis/HTLV-I-associated myelopathy. Recent …

Clinical and laboratory findings were examined for 111 human T-cell lymphotropic virus type
I (HTLV-I)-infected blood donors. HTLV-I provirus loads in subjects with a family history of …

Human T-lymphotropic virus type II (HTLV-II) is endemic among Amerindian tribes and is
also prevalent at high levels among certain US and European intravenous drug users …

Although early reports of an etiological role of HTLV-I in AIDS are not supported by
subsequent epidemiologic and biologic data, all AIDS specialists should be aware of the …

Using data obtained in national surveys of human T-lymphotropic virus type I (HTLV-I)-
associated myelopathy/tropical spastic paraparesis (HAM/TSP) conducted in Japan in 1987 …

That HTLV-I is not a latent infection is indicated by the detection of mRNA in the peripheral
blood and CNS of patients with HTLV-I infection and by the persisting humoral and cellular …

Human T-lymphotropic virus type I (HTLV-I) causes HTLV-I-associated myelopathy/tropical
spastic paraparesis and adult T cell leukemia in a small percentage of infected individuals …

Infection by the human T-cell lymphotropic virus type I (HTLV-I) causes T-cell activation by at
least two separate mechanisms. One mechanism involves activation of the T cells harboring …

A total of 113 patients with infection due to human T-cell leukemia virus type 1 (HTLV-I) were
evaluated at the University of Miami from January 1988 to March 1993. Forty patients were …